| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802521001010 | 252100101 | TRISENOX C/S.SOL.IN 10MG/10ML (1MG/ML) BTx10 AMPS x10ML | 2984.09 | 3028.85 | 3274.79 |
For induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression
The mechanism of action of Arsenic Trioxide is not completely understood. Arsenic trioxide causes morphological changes and DNA fragmentation characteristic of apoptosis in NB4 human promyelocytic leukemia cells <i>in vitro</i>. Arsenic trioxide also causes damage or degradation of the fusion protein PML/RAR-alpha. It is suspected that arsenic trioxide induces cancer cells to undergo apoptosis.
Symptoms of overdose include convulsions, muscle weakness and confusion.
Trivalent arsenic is mostly methylated in humans and excreted in urine.